Nutrition in inflammatory bowel disease.

S C Ling, A M Griffiths

Review Current opinion in clinical nutrition and metabolic care 2000 21 件の引用

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D11151077'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

研究タイプ: Review
対象集団: children

介入: Nutrition in inflammatory bowel disease. None
比較対照: None
主要アウトカム: inflammation markers
効果の方向: Positive
バイアスリスク: Unclear

Abstract

Recent developments concerning nutritional complications of inflammatory bowel disease include a better understanding of disease-associated anorexia and increasing recognition of the interaction of nutrition and cytokines in the pathogenesis of growth impairment of children. Decreased bone mineral density is a multifactorial complication and an increased focus of research. Enteral nutrition continues to play an important role in the therapy of Crohn's disease. The mechanisms whereby specific nutrients, such as n-3 fatty acids, antioxidants, and butyrate, ameliorate inflammation are being elucidated in in-vitro studies, but beneficial effects have yet to be translated into the clinical sphere.

要約

The mechanisms whereby specific nutrients, such as n-3 fatty acids, antioxidants, and butyrate, ameliorate inflammation are being elucidated in in-vitro studies, but beneficial effects have yet to be translated into the clinical sphere.

Used In Evidence Reviews

C L-Glutamine ： Crohn's Disease

C Butyrate (Sodium/Calcium Butyrate) ： Crohn's Disease

Nutrition in inflammatory bowel disease.

Embed This Widget

Study Design

Abstract

要約

Used In Evidence Reviews

Similar Papers

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.

The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition.

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.

Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.